November Performance | +60.1% Since July 2025
+ 5,000 bps of alpha in 5 months and + 1,500 bps in November alone.
The Aurelion Index is up 15.18% in November and up 60.06% since July 2025.
As a reminder, the Aurelion Index measures the performance of each of our Buy-Rating companies. We provide both real-time access to the Buy-Rating companies in the Index as well as complete extensive research coverage to our paid subscribers.
The Index is equally weighted. This means with 13 Buy-Rating companies at the moment, each position carries a portfolio weight of ~7.7%.
This is not financial advice in any way. Please conduct your own research.
November Performance
Our outperformance for November was clearly company specific.
Many of our companies reported their Q3 results and were up significantly on improved market sentiment and beat of earnings estimates.
An example is Bruker, which was up nearly 25.3% during the quarter.
BRKR reported growth in bookings as well as higher confidence about 2026 margins as per our investment thesis. We didn’t have any important detractor this quarter, as earnings results for all our buy-rating companies were in line with consensus, or in certain cases like Bruker, above estimates.
Our benchmark, the S&P 500 (which we view as the best comparable), finished November unchanged as conflicting forces offset each other. Large cap tech paused after a strong year, with softer guidance from several AI companies. At the same time, defensive sectors gained modestly as investors positioned for a slower growth backdrop and lingering rate uncertainty.
Mixed economic data kept expectations for easing policy stable rather than improving, which limited overall directional momentum for the index.
Performance Since Inception
Buy-Rating companies continue to outperform since we launched the Aurelion Index on July 1st. Our performance is driven by stock picking, fundamental analysis, and recognizing market trends early. Our goal is to cover a small set of high-conviction stocks and to become true experts on each of them, something most research teams cannot achieve because they are spread across too many names.
Portfolio Context
Our portfolio now includes 13 equally weighted core holdings across shipping, mining, life-science tools, defense, chemicals, and select financials.
Why We Win
With multiple years of institutional and retail investing experience our team knows how to both identify quality companies and enter the stock when the sentiment is right. Our goal is always to have an edge on the market, by visiting the companies facilities, meeting with the management team and its competitors as well as looking at alternative data.
We focus on companies that generate real cash flow and offer strong visibility into the durability and future growth of those cash flows.
We also maintain an active search for new themes and ideas, with a focus on value and momentum signals that emerge from broader market trends.
Alpha Performance
November contributed +1 503 bps of alpha versus the S&P 500, extending the Aurelion Index’s outperformance profile. Since inception, alpha has reached 4 970 bps, reflecting consistent excess return generation across periods.
We believe our approach supports sustained outperformance into 2026, as the portfolio is built on mid- to long-term ideas with durable fundamentals rather than short-term momentum, which drives consistency.